Pfizer Vaccine On Track For Regulatory Review In October

And biontech se said the covid 19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as october as they released additional data from an early stage study.

Pfizer vaccine on track for regulatory review in october. The coronavirus vaccine being jointly developed by pfizer and biontech se is currently on track to be submitted for regulatory review as early as october after they released additional data from an early stage study. Pedestrians wearing a protective mask walks past pfizer inc. Pfizer and biontech covid 19 vaccine on track for october regulatory review the covid 19 vaccine candidate from pfizer and biontech will move into final stage testing. Headquarters on july 22 2020 in new york city.

And biontech se said the covid 19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as october as they released additional data from an. And biontech se said the covid 19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as october as they released additional data from an. And biontech se said the covid 19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as october as they released additional data from an. By bloomberg news 21 aug 2020 07 01.

Pfizer vaccine on track for regulatory review in october says the vaccine is well tolerated with mild to moderate fever in fewer than 20 of the participants. Us pharma giant pfizer and its german partner biontech have announced that they are on track to submit their vaccine candidate for regulatory review as soon as october the companies released fresh data on thursday of their m rna vaccine against covid. Pfizer biontech vaccine on track for regulatory review in october pfizer and biontech se are continuing to analyse data from the phase 1 trials in the us and germany.